...
首页> 外文期刊>The Indian journal of medical research >Protection against osteoarthritis in experimental animals by nanogold conjugated snake venom protein toxin gold nanoparticle-Naja kaouthia cytotoxin 1
【24h】

Protection against osteoarthritis in experimental animals by nanogold conjugated snake venom protein toxin gold nanoparticle-Naja kaouthia cytotoxin 1

机译:纳米金共轭蛇毒蛋白毒素金纳米颗粒-Naja kaouthia细胞毒素1对实验动物的骨关节炎的保护

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background & objectives: Increased severity of osteoarthritis (OA) and adverse side effects of its treatment led to the search for alternative therapies. It was previously reported that snake venom protein toxin Naja kaouthia cytotoxin 1 (NKCT1) and gold nanoparticle (GNP) individually have potential against excremental arthritis. In this study, we analyzed the protective activity of GNP conjugated protein toxin NKCT1 (GNP-NKCT1) against experimental OA. Methods: Gold nanoparticle conjugation with NKCT1 (GNP-NKCT1) was done and its physiochemical properties were studied. OA was induced in male albino rats by intra-articular injection of bacterial collagenase and treatment was done with NKCT1/GNP-NKCT1/standard drug (indomethacin). Physical parameter (ankle diameter), urinary markers (hydroxyproline, glucosamine, pyridinoline, deoxypyridinoline), serum and synovial membrane pro-inflammatory markers [tumour necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), IL-17, vascular endothelial growth factor (VEGF)] and matrix metalloproteinase 1 (MMP1) were measured. Joint histopathology and scanning electron microscopy imaging of articular cartilage surface were also done. Results: Physical parameters, urinary markers, serum and synovial membrane pro-inflammatory makers and MMP1 were increased in arthritic rats and significantly restored after GNP-NKCT1/NKCT1 treatment. Joint histopathology and scanning electron microscopy imaging of articular cartilage surface also indicated the protective effect of GNP-NKCT1 against inflammatory response and cartilage degradation in osteoarthritic rats. Interpretation & conclusions: In this study restoration of the arthritic markers and bone degradation by GNP-NKCT1 treatment indicated the anti-osteoarthritic property of GNP-NKCT1. Further studies need to be done to confirm these findings.
机译:背景与目的:骨关节炎(OA)的严重程度增加及其治疗的不良副作用导致人们寻求替代疗法。以前有报道蛇毒蛋白毒素Naja kaouthia细胞毒素1(NKCT1)和金纳米颗粒(GNP)分别具有预防排泄性关节炎的潜力。在这项研究中,我们分析了GNP共轭蛋白毒素NKCT1(GNP-NKCT1)对实验性OA的保护活性。方法:完成了金纳米颗粒与NKCT1(GNP-NKCT1)的结合,并对其理化性质进行了研究。通过关节内注射细菌胶原酶诱导雄性白化病大鼠OA,并用NKCT1 / GNP-NKCT1 /标准药物(吲哚美辛)进行治疗。物理参数(脚踝直径),尿液标记物(羟脯氨酸,氨基葡萄糖,吡啶啉,脱氧吡啶啉),血清和滑膜促炎性标记物[肿瘤坏死因子-α(TNF-α),白介素-1β(IL-1β),IL-图17,测量了血管内皮生长因子(VEGF)和基质金属蛋白酶1(MMP1)。还进行了关节软骨表面的联合组织病理学和扫描电子显微镜成像。结果:GNP-NKCT1 / NKCT1处理后,关节炎大鼠的生理指标,尿液指标,血清和滑膜促炎物质及MMP1均升高,并显着恢复。关节软骨表面的联合组织病理学和扫描电子显微镜成像也表明,GNP-NKCT1对骨关节炎大鼠的炎症反应和软骨降解具有保护作用。解释与结论:在本研究中,通过GNP-NKCT1处理恢复了关节炎标志物和骨降解,显示了GNP-NKCT1的抗骨关节炎特性。需要做进一步的研究以证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号